Impact of blood collection devices on clinical chemistry assays

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 4-25

  Bowen, Raffick A R ^a   Hortin, Glen L ^b   Csako, Gyorgy ^c   Otañez, Oscar H ^a   Remaley, Alan T ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood collection devices; Clinical assay; Clinical chemistry; Interference; Phlebotomy; Preanalytical; Surfactant; Tube

Indexed keywords

ALCOHOL; ANTICOAGULANT AGENT; BENZODIAZEPINE; CITRATE TRISODIUM; CYCLOSPORIN; DISINFECTANT AGENT; EDETIC ACID; ELLAGIC ACID; FLUORIDE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; IODOACETIC ACID; LITHIUM; LUBRICATING AGENT; PHENOTHIAZINE; PLASTIC; POLYURETHAN; POVIDONE IODINE; PROTEINASE INHIBITOR; SILASTIC; SILICONE; SNAKE VENOM; SURFACTANT; TACROLIMUS; THIOPENTAL; THROMBIN; THROMBOPLASTIN; UNINDEXED DRUG; WARFARIN;

ABSORPTION; ADSORPTION KINETICS; ANALYTIC METHOD; ANALYTICAL ERROR; BLOOD COMPONENT; BLOOD SAMPLING; CATHETER; CELL INTERACTION; CLINICAL CHEMISTRY; CLINICAL LABORATORY; CYTOLYSIS; DRUG BLOOD LEVEL; DRUG MECHANISM; EQUIPMENT DESIGN; GEL; HUMAN; LABORATORY PERSONNEL; LABORATORY TEST; LITHIUM BLOOD LEVEL; MATERIAL COATING; NEEDLE; PLASMA; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; RISK REDUCTION; SERUM; SHEAR STRESS; SYRINGE; VASCULAR ACCESS DEVICE;

ANTICOAGULANTS; BIOLOGICAL ASSAY; BLOOD COAGULATION; BLOOD SPECIMEN COLLECTION; CATHETERIZATION; CHEMISTRY, CLINICAL; DISINFECTANTS; HISTORY, 20TH CENTURY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; NEEDLES; SPECIMEN HANDLING; SURFACE-ACTIVE AGENTS; SYRINGES;

EID: 72649094040     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.10.001     Document Type: Review

References (318)

1. Howard-Jones N. A critical study of the origins and early development of hypodermic medication. J. Hist. Med. Allied Sci. 2 (1947) 201-245
2. Lillenfiled A.M., Bross I., and Sartwell P.E. Observations on an outbreak of infectious hepatitis in Baltimore during 1951. Amer. J. Pub. Health 43 (1953) 1085-1096
3. Cree E.M., and Brown J.W. Observation on the epidemiology of infectious hepatitis. Lab. Clin. Med. 37 (1951) 104-121
4. Funderburk JV. "System for lubricating a syringe barrel", U.S. Patent No. 5,456,940, October 1995.
5. MacNutt M.J., and Sheel A.W. Performance of evacuated blood collection tubes at high altitude. High Alt. Med. Bio. 9 (2008) 235-237
6. Little M.A., Hussein T., Lambert M., and Dickson S.J. Percutaneous venepuncture practice in a large urban teaching hospital. Clin. Med. 7 (2007) 243-249
7. Hill B.M., Laessig R.H., Koch D.D., and Hassemer D.J. Comparison of plastic versus glass evacuated serum-separator (SST) blood drawing tubes for common chemistry determinations. Clin. Chem. 38 (1992) 1474-1478
8. Daves M., Trevisan D., and Cemin R. Different collection tubes in cardiac biomarkers detection. J. Clin. Lab. Anal. 22 (2008) 391-394
9. Bush V.J., Leonard L., and Szamosi D.I. Advancements in blood collection devices. Lab. Med. 29 (1998) 616-622
10. Bowen R.A.R., Chan Y., Cohen J., et al. Effect of blood collection tubes on total triidothyronine and other laboratory assay. Clin. Chem. 51 (2005) 424-433
11. Bowen R.A.R., Chan, Ruddel M.E., Hortin G.L., Csako G., Demosky S.J., and Remaley A.T. Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant Silwet L-720. Clin. Chem. 51 (2005) 1874-1882
12. Stankovic A.K., and Smith S. Elevated potassium values: the role of preanalytic variables. Am. J. Clin. Path. 121 (2004) S105-112
13. Burns E.R., and Yoshikawa N. Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists. Lab. Med. 33 (2002) 377-380
14. Meites S. Skin-puncture and blood-collecting techniques for infants: updates and problems. Clin. Chem. 34 (1988) 1890-1894
15. Blebea J., and McPherson R.A. False-positive guaiac testing with iodine. Arch. Pathol. Lab. Med. 109 (1985) 437-440
16. Bach P.R. When a sodium is not a sodium. Pediatr. Lab. Med. 9 (1991) 5
17. Higaki Y, Uchida Y. "Blood collection needle". U.S. Patent No. 7,267,653, September 2007.
18. Sunderman F.W., Crisostomo M.C., Reid M.C., Hopfer S.M., and Nomoto S. Ann. Clin. Lab. Sci. 14 (1984) 232-241
19. Lippi G., Salvagno G.L., Brocco G., and Guidi G.C. Preanalytical variability in laboratory testing: influence of the blood drawing technique. Clin. Chem. Lab. Med. 43 (2005) 319-325
20. Lippi G., Salvagno G.L., Montagnana M., Brocco G., and Guidi G.C. Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing. Clin. Chem. Lab. Med. 44 (2006) 1009-1014
21. Encyclopedia of surgery: a guide for patients and caregivers. http://www.surgeryencyclopedia.com/St-Wr/Syringe-and-Needle.html; (Accessed May 1, 2009).
22. Ernst D.J., and Ernst C. Phlebotomy tools of the trade. Home Health Nurse 20 (2002) 151-153
23. Sharp M.K., and Mohammad S.F. Hemolysis in needleless connectors for phlebotomy. ASAIO J. 49 (2003) 128-130
24. Yucel D., and Dalva K. Effect of in vitro hemolysis on 25 biochemical tests. Clin. Chem. 38 (1992) 575-577
25. Sharp M.K., and Mohammad S.F. Scaling of hemolysis in needles and catheters. Biomed. Eng. 26 (1998) 788-797
26. Wilcox G.J., Barnes A., and Modanlou H. Does transfusion using a syringe infusion pump and small-gauge needle cause hemolysis?. Transfusion 21 (1981) 750-751
27. Laessig R.H., Hassemer D.J., Paskey T.A., and Schwartz Th. The effects of 0.1% and 1.0% erythrocytes and hemolysis on serum chemistry values. Am. J. Clin. Pathol. 66 (1976) 639-644
28. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 88 (1996) 3456-3464
29. Spijker H.T., Graaff R., Boonstra P.W., Busscher H.J., and Van Oeveren W. On the influence of flow conditions and wettability on blood material interactions. Biomaterials 24 (2003) 4717-4727
30. Prabhu S., Kazarian T., Hakobyan N., Jabbar A., Dunham T., and Valentino L.A. Needles and needleless devices for infusion of anti-haemophilic factor concentrate: impact on protein structure and function. Haemophilia 12 (2006) 58-61
31. Carraro P., Servidio G., and Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge. Clin. Chem. 46 (2000) 306-307
32. Savory J., and Bill J.G. Hemolysis of specimens drawn in the ER [Q&A]. Lab. Med. 27 (1996) 802
33. Narayanan S., and Lin F.C. Sampling technique. In: Wong S.H.Y. (Ed). Therapeutic drug monitoring and toxicology by liquid chromatography (1985), Marcel Dekker, Inc, New York, NY 79-88
34. Khan AJ, Khan MA. "Medical device lubricant containing lecithin", U.S. Patent No. 5,824,359, October 1998.
35. Steube GA. "Medical device lubricant comprising radiation curable silicon material", U.S. Patent No. 7,354,628, April 2008.
36. Pelkey BJ. "Lubricant system for hypodermic needles and method for its application", U.S. Patent No. 5,911,711, June 1999.
37. Williams JL, Shepard TA. "Method for lubricating articles", U.S. Patent No. 5,186,972, February 1993.
38. Williamitis VA, Spielvogel DE. "Lubricated metal articles and assembly containing same", U.S. Patent No. 5,185,006, February 1993.
39. Hu CM, Solomon DD, Williamitis VA. "Method for preparing lubricated surfaces", U.S. Patent No. 4,842,889, June 1989.
40. Uyama Y., Tadokoro H., and Ikada Y. Surface lubrication of polymer films by photo induced graft polymerization. J. Appl. Polym. Sci. 39 (1990) 489-498
41. Kim B.S., Hrkach J.S., and Langer R. Biodegradable photo-cross linked poly (ether-ester) networks for lubricious coatings. Biomaterials 21 (2000) 259-265
42. Versieck J., and Cornelis R. Trace elements in human plasma or serum (1989), CRC Press, Boca Raton
43. Lippi G., Salvagno G.L., and Guidi G.C. No influence of a butterfly device on routine coagulation assays and D-dimer measurement. J. Thromb. Haemost. 3 (2005) 389-391
44. Lippi G., Franchini M., Montagnana, Salvagno G.L., Poli G., and Guidi G.C. Quality and reliability of routine coagulation testing: can we trust that sample. Blood Coagulation and Fibrinolysis 17 (2006) 513-519
45. Young D.S., Bermes E.W., and Haverstick D.M. Specimen collection and other preanalytical variables. In: Burtis C.A., Ashwood E.R., and Bruns D.E. (Eds). Fundamentals of clinical chemistry (2008), Elsevier Saunders
46. Lippi G., Blanckaert N., Bonini P., Green S., Kitchen S., Palicka V., Vassault A., and Plebani M. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin. Chem. Lab. Med. 46 (2008) 764-772
47. Pike E., Shuterud B., Kierulf P., Fremstad D., Abdel Sayal S.M., and Lunde P.K.M. Binding and displacement of basic, acidic, and neutral drugs in normal and orosomucoid-deficient plasma. Clin. Pharm. 6 (1981) 367
48. Petersen M.C., Vine J., Ashley J.J., and Nation R.L. Leaching of 2-(2-hydroxyethylmercapto) benzothiazole into contents of disposable syringes. J. Pharm. Sci. 70 (1981) 1139
49. Lehandro B. The next generation of prefillable syringes: specialized plastics lead the way. On Drug Delivery 7 (2007)
50. Clinical Laboratory Standards Institute. Blood gas and pH analysis and related measurements; approved guideline - Second Edition; C46-A2.
51. Verresen L., Lins R.L., Neels H., and DeBroe M.E. Effects of needle size and storage temperature on measurements of serum potassium. Clin. Chem. 32 (1986) 698-699
52. Ashavaid T.F., Dandekar S.P., Keny B., and Bhambhwani V.R. Influence of blood specimen collection method on various preanalytical sample quality indicators. Ind. J. Clin. Biochem. 23 (2008) 144-149
53. McGuff J., and Popovsky M.A. Needlestick injuries in blood collection staff. A retrospective analysis. Transfusion 29 (1989) 693-695
54. Bilski B. Needlestick injuries in nurses-the Poznań study. Int. J. Occup. Med. Environ. Health 18 (2005) 251-254
55. Eldridge F., and Fretwell L.K. Change in oxygen tension of shed blood at various temperatures. J. Appl. Physiol. 20 (1965) 790-792
56. Scott P.V., Horton J.N., and Mapleson W.W. Leakage of oxygen from blood and water samples stored in plastic and glass syringes. Br. Med. J. 3 (1971) 512-516
57. Winkler J.B., Huntington C.G., Wells D.E., and Befeler B. Influence of syringe material on arterial blood gas determinations. Chest 66 (1974) 518-521
58. Smeenk F., Janssen J., Arends B., Harff G., van den Bosch J., Schonberger J., and Postmus P.E. Effects of four different methods of sampling arterial blood and storage time on gas tensions and shunt calculation in the 100% oxygen test. Eur. Respir. J. 10 (1997) 910-913
59. 2 through the walls of plastic syringes. Can. J. Physiol. Pharmacol. 51 (1973) 608-611
60. Muller-Plathe O., and Heyduch S. Stability of blood gases, electrolytes and hemoglobin in heparinized whole blood samples: influence of the type of syringe. Eur. J. Clin. Chem. Clin. Biochem. 30 (1992) 349-355
61. 2 and pH in heparinized whole blood samples: influence of storage temperature with regard to leukocyte count and syringe material. Eur. J. Clin. Chem. Clin. Biochem. 30 (1992) 767-773
62. 02 calculated from blood stored in plastic and glass syringes. J. Appl. Physiol. 82 (1997) 196-202
63. Evers W., Racz G.B., and Levy A.A. A comparative study of plastic and glass syringes in blood gas analysis. Anaesth. Analg. 51 (1972) 92-97
64. Restall R.V.F., Miller S.E., Hahn C.E.W., Epstein H.G., and Foex P. Plastic or glass syringes: a comparison of the changes in oxygen tension when blood or water are stored in iced water. Br. J. Anaesth. 47 (1975) 636-637
65. Pretto J.J., and Rochford P.D. Effects of sample storage time, temperature, and syringe type on blood gas tensions in samples with oxygen partial pressures. Thorax 49 (1994) 610-612
66. Wiwanitkit V. Glass syringes are better than plastic for preserving arterial blood gas for oxygen partial pressure determination: an explanation based on nanomaterial composition. Int. J. Nanomed. 1 (2006) 223-224
67. Mahoney J., Harvey J., Wong R., and Van Kessel A. Changes in oxygen measurements when whole blood is stored in iced plastic or glass syringes. Clin. Chem. 37 (1991) 1244-1248
68. Liss H.P., and Payne Jr. C. Stability of blood gases in ice and at room temperature. Chest 103 (1993) 1120-1122
69. 2, and pH in fresh blood samples stored in a plastic syringe with low heparin in relation to various blood-gas and hematological parameters. Clin. Biochem. 32 (1999) 101-107
70. Knowles T.P., Mullin R.A., Hunter J.A., and Douce F.H. Effects of syringe material, sample storage time, and temperature on blood gases and oxygen saturation in arterialized human blood samples. Resp Care 51 (2006) 732-736
71. CLSI document H18-A3. Procedures for the handling and processing of blood specimens; approved guideline. 3rd edition, 2004.
72. Benoit M.O., and Paul J.L. Evaluation and advantages of an automatic magnetic mixing of syringes integrated with a whole blood gas analyzer. Scand. J. Clin. Lab. Invest. (2009) 1-5
73. Busca A., Miniero R., Vassallo E., et al. Monitoring of cyclosporine blood levels from central venous lines: a misleading assay?. Ther. Drug Monit. 16 (1994) 71-74
74. Leson C.L., Bryson S.M., Giesbrecht E.E., et al. Therapeutic monitoring of cyclosporine following pediatric bone marrow transplantation: problems with sampling from silicone central venous lines. DICP: Annals of Pharmacotherapy 23 (1989) 300-303
75. Carreras E., Lozano M., Deulofeu R., et al. Influence of different indwelling lines on the measurement of blood cyclosporine A levels. Bone Marrow Trans. 3 (1988) 637-639
76. Duffner U., Bergstraesser E., Sauter S., et al. Spuriously raised cyclosporine concentrations drawn through polyurethane central venous catheter. Lancet 352 (1998) 1442
77. Raisky F., Gauthier C., Marchal A., and Blum D. Haemolyzed samples: responsibility of short catheters. Ann. Biol. Clin. 52 (1994) 523-527
78. Kennedy C., Angermuller S., King R., Noviello S., Walker J., Warden J., et al. A comparison of hemolysis rates using intravenous catheters versus venepuncture tubes for obtaining blood samples. J. Emerg. Nurs. 22 (1996) 566-569
79. Gaylord M.S., Pittman P.A., Bartness J., et al. Release of benzalkonium chloride from a heparin-bonded umbilical catheter with resultant factitious hypernatremia and hyperkalemia. Peds 87 (1991) 631-635
80. Koch T.R., and Cook J.D. Benzalkonium interference with test methods for potassium and sodium. Clin. Chem. 36 (1990) 807-808
81. Caroll P. Only as good as the sample. Med. Econ. 60 (1997) 26-28
82. Grant M.S. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. J. Emerg. Nurs. 29 (2003) 116-121
83. Tanable P., Kyriacou D.N., and Garland F. Factors affecting the risk of blood bank specimen haemolysis. Academ. Emerg. Med. 10 (2003) 897-900
84. Moorhatch P., and Chiou W.L. Interactions between drugs and plastic intravenous fluid bags. Part 1: sorption studies on 17 drugs. Am. J. Hosp. Pharm. 31 (1974) 72-78
85. Parker W.A., Morris M.E., and Shearer C.A. Incompatibility of diazepam injection in plastic intravenous bags. Am. J. Hosp. Pharm. 36 (1979) 505-507
86. Cloyd J.C., Veseau C., and Miller K.W. Availability of diazepam from plastic containers. Am. J. Hosp. Pharm. 37 (1980) 492-496
87. Jostell K.G. Interaction between clomethiazole and pediatric intravenous administration sets. Acta Pharmac. Suecica 3 (1983) 61-67
88. Smith J.C., Davies M.C., Melia C.D., Denyer S.P., and Derrick M.R. Uptake of drugs by catheters: the influence of the drug molecule on sorption by polyurethane catheters. Biomaterials 17 (1996) 1469-1472
89. Grouzmann E., Buclin T., and Biollaz J. Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration. Am. J. Health. Syst. Pharm. 65 3 (2008) 226-228
90. Blifeld C., and Ettenger R.B. Measurement of cyclosporine levels in samples obtained from peripheral sites and indwelling lines. New Engl. J. Med. (1987) 317-509
91. de Witte T., Hoitsma A., Manoiu M.M., et al. Monitoring of cyclosporin during continuous intravenous administration. Bone Marrow Transplant 1 (1986) 147-150
92. Shulman R.J., Ou C., Reed T., et al. Central venous catheters versus peripheral veins for sampling blood levels of commonly used drugs. J. Parenter. Enteral. Nutr. 22 (1998) 234-237
93. Brinch L., Evensen S., Albrechtsen D., et al. Fooled by cyclosporine levels. Bone Marrow Trans. 9 (1992) 77-78
94. Claviez A., Gloass B., Dreger P., and Suttorp M. Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administration. Bone Marrow Trans. 29 (2002) 535-536
95. Vogler EA. "Blood collection assembly including mechanical phase separating insert", U.S. Patent No. 5,533,518, July 1996.
96. Serpentino P, Lin FC, Shankar H, Weir T. "Blood collection assembly and method therefore", U.S. Patent No. 6,077,235, February 1999.
97. Dubrowny NE, Harrop AJ. "Collection device", U.S. Patent No 6,686,204, February 2004.
98. Burns JA. "Blood microcollection tube assembly", U.S. Patent No. 5,288,466, February 1994.
99. Polack B., Schved J.F., and Boneu B. Preanalytical Recommendations of the "groupe d'etude sur l'hemostase et la thrombose' for venous blood testing in hemostasis laboratories". Haemost 31 (2001) 61-68
100. Polack 2007. Response to multicenter evaluation of a bilayer polymer blood coagulation tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers. Blood. Coagul. Fibrinolysis. 18 (2007) 709
101. Hulon W. "Blood collection tube assemply", U.S. Patent No. 5,297,561, March 1994.
102. Gorbet M., and Sefron M. Biomaterial-associated thrombosis: roles of coagulation factors, complement platelets and leukocytes. Biomaterials 25 (2004) 5681-5703
103. Ernst DJ. Plastic collection tubes decrease risk of employee injury. MLO. Med. Lab. Obs. 2001;33:44-6, 48,50.
104. Toulon P., Aillaud M.F., Arnoux D., Boissier E., Borg J.Y., and Gourmel C. Multicenter evaluation of a bilayer polymer blood collection tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers. Blood Coag Fibrino 17 (2006) 625-631
105. Anderson D.R., Wiseman J., MacLeod J., Burton E., and Zayed E. Evaluation of polyethylene terephthalate for ABO and Rh typing and alloantibody screening. Transfusion 40 (2000) 669-672
106. 2EDTA blood-drawing tubes for complete blood counts, reticulocyte counts, and white blood cell differentials. Lab. Hematol. 9 (2003) 10-14
107. Landt M., Wilhite T.R., and Smith C.H. A new plastic evacuated tube with plasma separator. J. Clin. Lab. Anal. 9 (1995) 101-106
108. Kratz A. A comparison of glass and plastic blood collection tubes for routine and specialized coagulation assays: a comprehensive study. Arch. Pathol. Lab. Med. 130 (2006) 39-44
109. Flanders M.M., Crist R., and Rodgers G.M. A comparison of blood collection in glass versus plastic vacutainers on results of esoteric coagulation assays. Lab. Med. 34 (2003) 732-735
110. Jones HD, Patras K. "Method for coating a blood collection device", U.S. Patent No. 6,428,527, August 2002.
111. Anraku H, Shoji Y, inventors. Vacuum blood collection tubes. U.S. Patent No. 8,565,334, August 1989.
112. Vogler EA, Harper GR, Graper JC. "Vacuum actuated blood collection assembly including tube of clot-accelerating plastic", U.S. Patent No. 5,344,611, September 1994.
113. Montgomery DB,Vogler EA. "Tube having regions of different surface chemistry and method therefore", U.S. Patent No. 5,318,806, June 1994.
114. Augello FA, Rainen L, Walenciak M, Oelmuller U, wyrich R, Bastian H. "Method and device for collecting and stabilizing a biological sample", U.S. Patent No. 6,602,718, November 2000.
115. Reinartz J.J., Ramey M.L., Fowler M.C., and Killeen A.A. Plastic vs. glass SST evacuated serum-separator blood drawing tubes for endocrinologic analytes. Clin. Chem. 39 (1993) 2535-2536
116. Boeynaems J.M., DeLeener A., Dessars B., Villakobos H.R., Aubry J.C., Cotton F., et al. Evaluation of new generation of plastic evacuated blood collection tubes in clinical chemistry, therapeutic drug monitoring, hormone and trace metal analysis. Clin. Chem. Lab. Med. 42 (2004) 67-71
117. Preissner C.M., Reilly W.M., Cyr R.C., O'Kane D.J., Singh J., and Grebe S.K.G. Plastic versus glass tubes: effects on analytical performance of selected serum and plasma hormone assays. Clin. Chem. 50 (2004) 1245-1247
118. Landry M.L., Garner R., and Ferguson D. Use of plastic Vacutainer tubes for quantification of human immunodeficiency virus type I in blood specimens. J. Clin. Microbiol. 39 (2001) 354-356
119. Feng C.S., and Wan C.P. The plastic tube compared with the glass tube in blood bank tests. Pathol 20 (1988) 309-310
120. Black D., and Kay J. Influence of tube type on the antiglobulin test. Med. Lab. Sci. 43 (1986) 169-173
121. Polack B., Barro C., Pernod G., Bourgeat P., and Vigier J.P. Impact of the blood collection tube on the activation of coagulation. Thromb. Haemost. 77 (1997) 217-218
122. Biron-Andreani C., Mallol C., Seguret F., and Schved J.F. Plastic vs. siliconized glass tubes: evaluation in clinical practice. Thromb. Haemost. 83 (2000) 800-801
123. van den Besselaar A.M.H.P., Meeuwisse-Braun J., Witteveen E., and Van Meegen E. Effect of evacuated blood collection tubes on thromboplastin calibration. Thromb. Haemost. 79 (1998) 1062-1063
124. Flanders M.M., Crist R., and Rodgers G.M. Comparison of five thrombin time reagents. Clin. Chem. 49 (2003) 169-172
125. Stankovic A.K., and Parmar G. Assay interferences from blood collection tubes: a cautionary note. Clin. Chem. 52 (2006) 1627-1628
126. Selby C. Interference in immunoassay. Ann. Clin. Biochem. 36 (1999) 704-721
127. Wood W.G., and Gadow A. Immobilization of antibodies and antigens on macro solid phases-a comparison between adsorptive and covalent binding. A critical review of macro solid phases for use in immunoassay systems. J. Clin. Chem. Clin. Biochem. 21 (1983) 789-797
128. Gadow A., Fricke H., Strasburger C.J., and Wood W.G. Synthesis and evaluation of luminescent tracers and hapten-protein conjugates for use in luminescence immunoassays with immobilized antibodies and antigens. A critical study of macro solid phases for use in immunoassay systems, part II. J. Clin. Chem. Clin. Biochem. 22 5 (1984) 337-347
129. Nugent E, Losada RJ, Conway HT, Montgomery DB, Williams JL. "Platelet stable blood collection assembly", U.S. Patent No. 4,967,763, March 1989.
130. Vogler EA, Harper GR. "Surface modified blood collection tubes", U.S. Patent No. 5,257,633, June 1992.
131. Sachs C., Rabouine P., Chaneac M., Kindermans C., and Decbaux M. Anticoagulant-induced preanalytical errors in ionized calcium determination on blood. Scan. J. Clin. Lab. Invest. 49 (1989) 647-651
132. Cao Z., Tongate C., and Elin R.J. Evaluation of AVL 988/4 analyzer for measurement of ionized magnesium and ionized calcium. Scand. J. Lab. Invest. 61 (2001) 389-394
133. Marsoner H.J., Spichiger U.E., Ritter C., Sachs C., Ghahramani M., Offenbacher H., et al. Measurement of ionized magnesium with neutral carrier based ISEs. Progress and results with the AVL 988-4 magnesium analyzer. Scand. J. Clin. Lab. Invest. 217 (1994) 45-51
134. Zoppi F., De Gasperi A., Guagnellini E., Marocchi A., Mineo E., Pazzucconi F., et al. Measurement of ionized magnesium with AVL 988/4 electrolyte analyzer: preliminary analytical and clinical results. Scand. J. Clin. Lab. Invest. 224 (1996) 259-274
135. Sampson M., Ruddel M., Albright S., and Elin R.J. Positive interference in lithium determinations from clot activator in collection container. Clin. Chem. 43 (1997) 675-679
136. Sachs C., Ritter C., and Puaud A.C. Measurement of ionized magnesium with an ion-selective electrode. In: Aizawa M., and Kuwa K. (Eds). Methodology and clinical applications of pH, blood gases and electrolytes and sensor technology (1992), Gene Act Planning Corp., Tokyo 177-181
137. Sachs C., Ritter C., Ghairamani M., Kindermans C., Deciaux M., and Marsoner H. Silicon; a cause of preanalytical error in ionized magnesium measurements. Magnes. Res. 6 (1993) 59-60
138. Davies C. Concepts. In: Wild D. (Ed). The immunoassay handbook. 2nd ed. (2001), Nature Publ Grp, UK 78-110
139. Galligan J., Ward G., Jacobi J., and McMaugh C. Preanalytical variation in samples collected for assay of adrenocorticotrophin. Clin. Biochem. 17 (1996) 100
140. Kilinc A.S., Duzoylum A., Uncugil C.F., and Yucel D. Falsely increased free triidothyronine in sera stored in serum separator tubes. Clin. Chem. 48 (2002) 2296-2297
141. Wickus G.G., Mordan R.J., and Mathews E.A. Interference in the Allegro immunoassay system when blood is collected in silicone-coated tubes [letter]. Clin. Chem. 38 (1992) 2347-2348
142. FDA enforcement report. Available at http://www.fda.gov.laneproxy.stanford.edu/bbs/topics/ENFORCE/ENFOO484.html. Retrieved December, 2008.
143. Harrop AJ, Dubrowny N. "Collection device for blood", Eur Patent No. 1,162,463, August 2003.
144. Cohen R, Dastane AN. "Additive preparation and method of use thereof", U.S. Patent No. 6,534,016, March 2003.
145. Zhang X.D., Macosko C.W., Davis H.T., Nikolov A.D., and Wasan D.T. Role of silicone surfactant in flexible polyurethane foam. J. Colloid. Interface. Sci. 215 (1999) 270-279
146. Byun J.W., Kim J.U., Chung W.J., and Lee Y.S. Surface-grafted polystyrene beads with comb-like poly (ethylene glycol) chains: preparation and biological application. Macromol. Biosci. 4 (2004) 512-519
147. Wang HC, Wong WK. "Cured rubber components for use with pharmaceutical devices", U.S. Patent No, 7,282,269 December 2002.
148. Kessler SB. Apparatus for the separation of blood components. U.S. Patent No. 2,578,864, March 1981.
149. Morovat A., James T.S., Cox S.D., et al. Comparison of Bayer Advia Centaur® immunoassay results obtained on samples collected in four different Becton Dickinson Vacutainer® tubes. Ann. Clin. Biochem. 43 (2006) 481-487
150. Wang S., Ho V., Roquemore-Goins A., and Smith F.A. Effects of blood collection tubes, including pediatric devices, on 16 common immunoassays. Clin. Chem. 52 (2006) 892-893
151. McKiel R.R., Barron N., Needham C.J., and Wilkins T.A. Siliconized vs. nonsiliconized evacuated blood-collection tubes for free thyroxin measurements. Clin. Chem. 2333 (1982) 28
152. Chang C., Lu J., Chien T., Kao J., Lin J., Shih P., et al. Interference caused by the contents of serum separator tubes in the Vitros CRP assay. Ann. Clin. Biochem. 40 (2003) 249-251
153. Sheffield J.S., Laibl V.R., Roberts S.W., and Wendel G.D. False positive results for the AUSZYME monoclonal test. Obstet. Gynecol. 105 (2005) 449-450
154. Ottinger W.E. Q&A. Lab. Med. 37 (2006) 40-41
155. Drake S.K., Bowen R.A.R., Remaley A.T., and Hortin G.L. Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. Clin. Chem. 50 (2004) 2398-2401
156. Luque-Garcia J.L., and Neubert T.A. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. J. Chromatogr. A. 1153 1-2 (2007) 259-276
157. 3) concentration: a model for studying interference from tube constituents. Clin. Chem. Acta 378 (2007) 181-193
158. Percarpio EP, Holderith WJ, Wyckoff. "Vacuum indicator closure for a blood collection tube", U.S. Patent No. 4,293,078, November 1979.
159. Cook BW, Fiehler WR. "Medical container stopper", U.S. Patent No. 5,060,659, October 1991.
160. Cornell WD. "Fluid collection device with phase partitioning means", U.S. Patent No. 4,055,501, January 1976.
161. Shah V.P., Knapp G., Skelly J.P., and Cabana B.E. Drug assay interference caused by plasticizer in vacutainers. Am. J. Hosp. Pharm. 39 (1982) 1454
162. Shah V.P., Knapp G., Skelly J.P., and Cabana B.E. Interference with measurements of certain drugs in plasma by a plasticizer in Vacutainer tubes. Clin. Chem. 2327 (1982) 28
163. Cotham R.H., and Shand D. Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin. Pharmacol. Ther. 18 (1975) 535-538
164. Kessler K.M., Leech R.C., and Spann J.F. Blood collection techniques, heparin and quinidine protein binding. Clin. Pharmacol. Ther. 25 (1979) 204
165. Stargel W.W., Roe C.R., Routledge P.A., and Shand D.G. Importance of blood-collection tubes in plasma lidocaine determinations. Clin. Chem. 25 (1979) 617
166. Quattrocchi F., Karnes T., Robinson D., and Hendeles L. Effect of serum separator blood collection tubes on drug concentrations. Ther. Drug. Monit. 5 (1983) 359-362
167. 1-acid glycoprotein by tris (2-butoxyethyl) phosphate. Clin. Pharmacol. Ther. 22 (1977) 539-544
168. Devine J.E. Drug-protein binding interferences caused by the plasticizer TBEP. Clin. Biochem. 17 (1984) 345-347
169. Janknegt R., Lohman J.J., Hooymans P.M., and Merkus F.W. Do evacuated blood collection tubes interfere with therapeutic drug monitoring?. Pharm. Weekbl. Sci. Ed. 5 (1983) 287-290
170. Chrzanowski F. Interference by butyl rubber stoppers in GLC analysis for theophylline. J. Pharm. Sci. 65 (1976) 735-736
171. Van den Besselaar A.M.H.P., Van dam W., Sturk A., and Bertina R.M. Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes. Thromb. Haemost. 85 (2001) 647-650
172. Van den Besselaar A.M.H.P., Rutten W.P.F., and Witteveen E. Effect of magnesium contamination in evacuated blood collection tubes on the prothrombin time test and ISI calibration using recombinant human thromboplastin and different types of coagulometer. Thromb. Res. 115 (2005) 239-244
173. Williams D.M. Trace-metal determinations in blood in evacuated collection tubes. Clin. Chem. Acta 99 (1979) 23-29
174. Dimeski G., and Carter A. Magnesium contamination from Terumo blood collection tubes. Clin. Chem. 52 (2006) 1612-1614
175. Cummings J. Evacuated tubes for monitoring heparin treatment. Thromb. Haemost. 34 (1981) 939-940
176. Cohen RR. "Evacuated sample collection tube with aqueous additive", US patent No 5,860,937, January, 1999.
177. Baum D. Glycerol lubricant: potential source of error in commercially prepared blood specimen tubes. Clin. Chem. 42 (1968) 73-74
178. Chowdry F.R., Rodman H., and Bleicher S.J. Glycerol-like contamination of commercial blood sampling tubes. J. Lipid Res. 12 (1971) 116
179. Bush V.J., Janu M.R., Bathur F., Wells A., and Dasgupta A. Comparison of BD Vacutainer SST plus tubes and BD SST II plus tubes for common analytes. Clin. Chem. 306 (2001) 139-143
180. Boyanton Jr. B.L., and Blick K.E. Stability studies of twenty-four analytes in human plasma and serum. Clin. Chem. 48 (2002) 2242-2247
181. Landt M., Smith C.H., and Hortin G.L. Evaluation of evacuated blood-collection tubes: effects of three types of polymeric separators on therapeutic drug-monitoring specimens. Clin. Chem. 39 (1993) 1712-1717
182. Heins M., Heil W., and Withold W. Storage of serum or whole blood samples? Effects of time and temperature on 22 serum analytes. Eur. J. Clin. Chem. Clin. Biochem. 33 (1995) 231-238
183. Dousmas B.T., Hause L.L., Simuncak D.M., and Breitenfeld D. Differences between values for plasma and serum in tests performed in the Ektachem 700 XR analyzer, and evaluation of "plasma separator tubes. Clin. Chem. 35 (1989) 151-153
184. Lin F.C., Cohen R., Losada R., and Bush V. Cellular sedimentation and barrier formation under centrifugal force in blood collection tubes. Lab. Med. 32 (2001) 588-592
185. Gigliello JF, Kragle HA. "Method and apparatus for multiphase fluid collection and separation", U.S. Patent No. 3,920,549, November 1975.
186. Spiritus T., Zaman Z., and Desmet W. Iodinated contrast media interfere with gel barrier formation in plasma and serum separator tubes. Clin. Chem. 49 (2003) 1187-1189
187. Kessler SB. Novel assembly for separating blood. U.S. Patent No 3,986,962, October 1976.
188. Coleman CM, Kendrick WG. "Separator float for blood collection tubes with water swellable material", U.S. Patent No. 5,736,033, April 1998.
189. Lukas MJ, Jacoby IH. "Serum separating method", U.S. Patent No. 3,780,935, December 1973.
190. Fatas M., Franquelo P., and Franquelo R. Anomalous flotation of separator gel: density or viscosity?. Clin. Chem. 54 (2008) 771-772
191. Fiehler WR. "Serum separation blood collection tube and the method of using thereof", U.S. Patent No. 5,236,604, August 1993.
192. Van den Ouweland J.M.W., and Church S. High total protein impairs appropriate gel barrier formation in BD Vacutainer blood collection tubes. Clin. Chem. 53 (2007) 364-365
193. Dasgupta A., Dean R., Saldana S., Kinnaman G., and McLawhon R.W. Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes: volume and time dependent reduction in total and free drug concentrations. Am. J. Clin. Pathol. 101 (1994) 456-461
194. Dasgupta A., Blackwell W., and Bard D. Stability of therapeutic drug measurement in specimens collected in Vacutainer plastic blood collection tubes. Ther. Drug. Monit. 18 (1996) 306-309
195. Karppi J., Akerman K.K., and Parviainen M. Suitability of collection tubes with separator gels for collecting and storing blood samples for therapeutic drug monitoring. Clin. Chem. Lab. Med. 38 (2000) 313-320
196. Bush V, Blennerhasset J, Wells A, Dasgupta A. Stability of therapeutic drugs in serum collected in vacutainer serum separator tubes containing new gel (SST II). Ther Drug Monit 2001;23:259-62.
197. Berk S.I., Litwin A.H., Du Y., Cruikshank G., Gourevitch M.N., and Arnsten J.H. False reduction in serum methadone concentrations by BD Vacutainer serum separator tubes. Clin. Chem. 52 (2006) 1972-1974
198. Dasgupta A, Yared MA, Wells A. Time-dependent absorption of therapeutic drugs by the gel of the Greiner Vacuette blood collection tube. Ther Drug Monit 2000;22:427-31.
199. Dasgupta A., Blackwell W., and Bard D. Stability of therapeutic drug measurement in specimens collected in Vacutainer plastic blood-collection tubes. Ther. Drug Monit. 18 (1996) 306-309
200. Bergvist Y., Eckerbom S., and Funding L. Effect of use of gel-barrier sampling tubes on determination of some antiepileptic drugs in serum. Clin. Chem. 30 (1984) 465-466
201. Koch T.R., and Platoff G. Suitability of collection tubes with separator gels for therapeutic drug monitoring. Ther. Drug Monit. 12 (1990) 277-280
202. Longnecker M.P., Bernstein L., Bird C.L., Yancey A.K., and Peterson J.C. Measurement of organochlorine levels in postprandial serum or in blood collected in serum separator tubes. Cancer Epidemiology; Biomarkers & Prevention 5 (1996) 753-755
203. Wilde C. Subject preparation, sample collection, and handling. In: Wild D. (Ed). The immunoassay handbook (2005), Elsevier, NY 243-255
204. ™ II blood collection tube for special chemistry analytes. Clin. Chem. Lab. Med. 47 (2009) 358-361
205. Murthy V.V. Unusual interference from primary collection tube in a high-performance liquid chromatography assay of amiodarone. J. Clin. Lab. Anal. 11 (1997) 232-234
206. Conway HT. Device and method for separating components of a liquid sample. U.S. Patent No. 6,537,503, March 2003.
207. Ji S.Q., and Evenson M.A. Effects of contaminants in blood-collection devices on measurement of therapeutic drugs. Clin. Chem. 29 (1983) 456-461
208. Streete P.J., and Flanagan R.J. Ethylbenzene and xylene from Sarstedt Monovette serum gel blood collection tubes. Clin. Chem. 39 (1993) 1344-1345
209. Grippi NA. "Blood collection assembly including clot-accelerating glass insert", U.S. Patent No. 5,634,474, June 1997.
210. Ali K. "Methods for improving uniformity of silica films on substrates", U.S. Patent No. 4,420,517, May 1982.
211. Vogler EA, Harper GR, Graper JC. "Vacuum actuated blood collection assembly including tube of clot-accelerating plastic", U.S. Patent No. 5,344,611, September 1994.
212. Kasai M, Yamazaki S. "Blood collection tube", U.S. Patent No. 5,213,765, May 1993.
213. Vogler E, Graper J. "Dual pathway clotting enhancer for blood collection tube", U.S. Patent No. 5,378,431, June 1993.
214. Vogler E, Graper J. "Particle for enhancing clotting in a blood collection tube by activation of dual pathway, blood collection assembly and method for preparing the particles", Eu. Patent No. 0,628,816, December 1998.
215. Kessler SB. "Method for collection blood", U.S. Patent No. 4,153,739, June 1977.
216. Babson AL. "Collection and separation device", U.S. Patent No. 4,152,269, May 1979.
217. Nosanchuk J.S. False increases in troponin I attributable to incomplete separation of serum [letter]. Clin. Chem. 45 (1999) 714
218. Beyne P., Vigier J.P., Bourgoin P., and Vidaud M. Comparison of single and repeated centrifugation of blood specimens collected in BD evacuated blood collection tubes containing a clot activator for cardiac troponin I assay on the ACCESS analyzer. Clin. Chem. 46 (2000) 1869-1870
219. Ooi D.S., and House A.A. Cardiac troponin T in hemodialyzed patients. Clin. Chem. 44 (1998) 1410-1416
220. Roberts W.L., Calcote C.B., De B.K., Holmstrom V., Narlock C., and Apple F.S. Prevention of analytical false-positive increases of cardiac troponin I on the Stratus II analyzer. Clin. Chem. 43 (1997) 860-861
221. Wang C., Shiraishi S., Leung A., et al. Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: interference and comparison with established methods. Steroids 73 (2008) 1345-1352 Epub 2008 May 21
222. Banks R.E., Stanley A.J., Cairns D.A., Barrett J.H., Clarke P., Thompson D., et al. Influences of blood sample processing on low-molecular weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin. Chem. 51 (2005) 637-649
223. Pilny R., Bouchal P., Borilova S., Ceskova P., Zaloudik J., Vyzula R., et al. Surface-enhanced laser desorption ionization/time-of-flight mass spectrometry reveals significant artifacts in serum obtained from clot activator-containing collection devices. Clin. Chem. 52 (2006) 2115-2116
224. Mannello F., Tanus-Santos J.E., Meschiari C.A., and Tonti G.A. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Anal. Biochem. 374 (2008) 56-63
225. Mannello F. Serum or plasma samples? The "Cinderella" role of blood collection procedures preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 611-614
226. Jung K. In serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy. Br. J. Can. 99 (2008) 553-554
227. Ladenson J.H., Tsai L.M.B., and Michael J.M. Serum versus heparinized plasma for eighteen common chemistry tests. Am. J. Clin. Pathol. 62 (1974) 545-552
228. Lutomski D.M., and Bower R.H. The effect of thrombocytosis on serum potassium and phosphorus concentrations. Am. J. Med. Sci. 307 (1994) 255-258
229. Lundblad R.L. Considerations for the use of blood plasma and serum for proteomic analysis. Internet. J. Genomics and Proteomics 2 (2005) 1-16
230. Hortin G.L. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin. Chem. 52 (2006) 1223-1237
231. Fukasawa H., Furuya R., Kato A., Yonemura K., Fujigaki Y., Yamamoto T., et al. Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis. Clin. Nephrol. 6 (2002) 451-454
232. Sevastos N., Theodossiades G., Efstathiou S., Papatheodoridis G.V., Manesis E., and Archimandritis A.J. Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude. J. Lab. Clin. Med. 147 (2006 Mar) 139-144
233. Assembly and method to improve vacuum retention in evacuated specimen containers. http://www.Freshpatents.com/dt20090625ptan200901625.php. (Accessed April 2009).
234. Haab B.B., Geierstanger B.H., Michailidis G., et al. Immunoassay and antibody microarray analysis of the HUPO plasma proteome project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 5 (2005) 3278-3291
235. Marcovina S., Coppola R., Valsecchi C., et al. Monoclonal antibodies directed to the calcium free conformation of human protein S. Thromb. Haemost. 62 (1989) 708-714
236. Einhauer A., and Jungbauer A. Complex formation of a calcium-dependent antibody: a thermodynamical consideration. J. Chromatogr. A 1009 (2003) 81-87
237. Lopez J.B., and Peng C.L. Can fluoride-oxalate and sodium citrate stabilize homocysteine levels after blood collection?. Clin. Chem. Lab. Med. 41 (2003) 1369-1372
238. Bray G.L., Weinmann A.F., and Thompson A.R. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders. J. Lab. Clin. Med. 107 (1986) 269-278
239. Clinical Laboratory Standards Institute. Tubes and additives for venous blood specimen collection. Approved Standard, H1-A5, Villanova, 2003.
240. Clinical Laboratory Standards Institute: Procedures for the collection of diagnostic blood specimens by venipuncture; approved standard, H3-A4; - Fourth Edition.
241. Young D.S., Bermes E.W., and Haverstick D.M. . Specimen collection and processing. In: Burtis C.A., Ashwood E.R., and Bruns D.E. (Eds). Tietz textbook of clinical chemistry and molecular diagnostics. 4th Ed. (2006), Elservier Saunders, St. Louis
242. Becton Dickinson Web site www.bd.com. (Accessed May 2009).
243. Kumara T., Hino M., Yamane T., and Tatsumi N. Hirudin as an anticoagulant for both hematology and chemistry tests. J. Auto. Methods Mgmt. Chem. 22 4 (2000) 109-112
244. Butler J. Negative interference in immunoassays. Clin. Chem. 41 (1995) 481-482
245. Tate J., and Ward G. Interferences in immunoassay. Clin. Biochem. 25 (2004) 105-120
246. Jones A.M., and Honour J.W. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin. Endocrinol. 64 (2006) 234-244
247. Glendenning P., Laffer L.L., Weber H.K., Musk A.A., and Vasikaran S.D. Parathyroid hormone is more stable in EDTA plasma than in serum. Clin. Chem. 48 (2002) 766-767
248. Banfi G., Salvagno G.L., and Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin. Chem. Lab. Med. 45 (2007) 565-576
249. Narayanan S. The preanalytic phase: an important component of laboratory medicine. Am. J. Clin. Pathol. 113 (2000) 429-452
250. Guder W., Ehret W., Fonseca-Wollheim F.D., et al. Serum, plasma or whole blood? Which anticoagulants to use. J. Lab. Med. 22 (1998) 297-312
251. Urban P., Buchmann B., and Schneidegger D. Facilitated determination of ionized calcium. Clin. Chem. 31 (1985) 264-266
252. Toffaletti J. Use of novel preparations of heparin to eliminate interference in ionized calcium measurements have all the problems been solved?. Clin. Chem. 40 (1994) 508-509
253. Yip P.M., Chan M.K., Zielinski N., and Adeli K. Heparin interference in whole blood sodium measurements in a pediatric setting. Clin. Biochem. 39 (2006) 391-395
254. Shek C.C., and Swaminathan R. Errors due to heparin in the estimation of plasma sodium and potassium concentrations. Intensive Care Med. 11 (1985) 309-311
255. Landt M., Hortin G.L., Smith C.H., McClellan A., and Scott M.G. Interference in ionized calcium measurements by heparin salts. Clin. Chem. 40 (1994) 565-570
256. Toffaletti J.R., and Wildermann R.F. The effects of heparin anticoagulants and fill volume in blood gas syringes on ionized calcium and magnesium measurements. Clin. Chem. Acta 304 (2001) 147-151
257. Rayana M.C.B., Burnett R.W., Covington A.K., et al. Recommendation for measuring and reporting chloride by ISEs in undiluted serum, plasma or blood. Clin. Chem. 44 (2006) 346-352
258. Gerhardt W. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin. Chem. 46 (2000) 817-821
259. Zaninotto M. Quality specifications for biochemical markers of myocardial injury. Clin. Chimica Acta 346 (2004) 65-74
260. Fornasieri A., Armelloni S., Bernasconi P., Li M., de Septis C.P., Sinico R.A., and D'Amico G. High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis?. Am. J. Kidney Dis. 4 (1996) 476-483
261. Kallemuchikkal U., and Gorevic P.D. Evaluation of cryoglobulins. Arch. Pathol. Lab. Med. 123 (1999) 119-125
262. Meng Q.H., and Krahn J. Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients. Clin. Chem. Lab. Med. 46 (2008) 396-400
263. Holland N.T., Smith M.T., Eskenazi B., and Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat. Res. 543 (2003) 217-234
264. Landi M.T., and Caporaso N. Sample collection, processing and storage. IARC Sci. Publ. (1997) 223-236
265. Tammen H., Schulte I., Hess R., Menzel C., Kellmann M., Mohring T., and Schulz-Knappe P. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 13 (2005) 3414-3422
266. Bosworth T.L., Sampson M., and Remaley A.T. Effect of contamination of heparinized blood collection tubes with oversulfated chondroitin sulfate. Clin. Chem. 55 (2009) S6:A22
267. Important safety information. www.bd.com/resource.aspx?IDX=4869. (Accessed May 2009).
268. Salzman E.W., Kensler P.C., and Levine L. Cyclic 3′5′-adenosine monophosphate in human blood platelets: regulatory role of cyclic AMP in platelet function. Ann. N. Y. Acad. Sci. 201 (1972) 61-71
269. Mills D.C.B., and Smith J.B. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′5′-cyclic monophosphate in platelets. Biochem. J. 121 (1971) 185-196
270. Constant G., Gouault-Heilmann M., and Martinoli J.L. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-CTAD mixture. Thromb. Res. 31 (1983) 365-374
271. Feig S.A., Shohet S.B., and Nathan D.G. Energy metabolism in human erythrocytes: I. Effects of sodium fluoride. J. Clin. Invest. 50 (1971) 1731-1737
272. Chan A.Y.W., Swaminathan R., and Cockram C.S. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin. Chem. 35 (1989) 315-317
273. Astles R., Williams C.P., and Sedor F. Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clin. Chem. 40 (1994) 1327-1330
274. Gambino R. Glucose: a simple molecule that is not simple to quantify. Clin. Chem. 53 (2007) 2040-2041
275. Gambino R., Piscitelli J., Ackattupathil T.A., Theriault J.L., Andrin R.D., Sanfilippo M.L., et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin. Chem. 55 (2009) 1019-1021
276. Waring W.S., Evans L.E., and Kirkpatrick C.T. Glycolysis inhibitors negatively bias blood glucose measurements: potential impact on the reported prevalence of diabetes mellitus. J. Clin. Pathol. 60 (2007) 820-823
277. Mikesh L.M., and Bruns D.E. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. Clin. Chem. 54 (2008) 930-932
278. Bruns D.E., and Knowler W.C. Stabilization of glucose in blood specimens: why it matters. Clin. Chem. 55 (2009) 1019-1021
279. Hall P.M., and Cook J.G.H. Fluoride and iodoacetate interfere with glucose determination with Yellow Springs glucose analyzer. Clin. Chem. 28 (1982) 387-388
280. Robertson E.A., Chesler R.A., and Elin R.J. Serum collected with lithium iodoacetate is unsuitable for electrolyte and lactate dehydrogenase measurements. Clin. Chem. 26 (1980) 1229-1230
281. Calam R., and Cooper M. Recommended "order of draw" for collecting blood specimens into additive-containing tubes. Clin. Chem. 28 (1982) 1399
282. H3-A5. National Committee for Clinical Laboratory Standards. Procedure for the collection of diagnostic blood specimens by venipuncture. Approved standard. Villanova 2003.
283. Procedures and devices for the collection of diagnostic blood specimens by skin puncture; approved standard. 4th edition. NCCLS H4-A4 September 1999.
284. CLSI. Collection, transport and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline-fifth edition. CLSI document H21-A5. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
285. Hortin G.L., Sviridov D., and Anderson N.L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 54 (2008) 1608-1616
286. Lyon M.E., Harding S.R., Oosman S.N., and Lyon A.W. Evaluation of argatroban and DUP 714 as anticoagulants for blood gas, electrolyte and ionized calcium analyses. Scand. J. Clin. Lab. Invest. 60 (2000) 19-26
287. Menssen H.D., Brandt N., Leben R., Muller F., Thiel E., and Melber K. Measurement of hematological, clinical chemistry, and infection parameters from hirudinized blood collected in universal blood sampling tubes. Semin. Thromb. Hemost. 27 (2001) 349-356
288. Cavalier E., Delanaye P., Carlisi A., Krzesinski J.M., and Chapelle J.P. Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney Int. 72 (2007) 370-372
289. Joly D., Drueke T.B., Alberti C., Houillier P., Lawson-Body E., Martin K.J., et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: cross-sectional study. Am. J. Kidney Dis. 51 (2008) 987-995
290. Evans M.J., Livesey J.H., Ellis M.J., and Yandle T.G. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin. Biochem. 34 (2001) 107-112
291. Kim W., and Egan J.M. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol. Rev. 60 (2008) 470-512
292. Rai A.J., Gelfand C.A., Haywood B.C., Warunek D.J., Yi J., Schuchard M.D., et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5 (2005) 3262-3277
293. Yi J., Kim C., and Gelfand C.A. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J. Proteome. Res. 6 (2007) 1768-1781
294. Schuchard M.D., Mehigh R.J., Cockrill S.L., Lipscomb G.T., Stephan J.D., Wildsmith J., et al. Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by 2-dimensional electrophoresis and mass spectrometry. Biotechniques 39 (2005) 239-247
295. Nilsson T.K., Boman K., Jansson J.H., Thogersen A.M., Berggren M., Broberg A., et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at - 70 degrees C for 8-11 years. Thromb. Res. 116 (2005) 249-254
296. Hortin G.L., Warshawsky I., and Laude-Sharp M. Macromolecular chromogenic substrates for measuring proteinase activity. Clin. Chem. 47 (2001) 215-222
297. Sapin R., Ongagna J.C., Gasser F., and Grucker D. Insulin measurements in haemolysed serum: influence of insulinase inhibitors. Clin. Chem. Acta 274 (1998) 111-117
298. Ayache S., Panelli M., Marincola F.M., and Stroncek D.F. Effects of storage time and exogenous protease inhibitors on plasma protein levels. Am. J. Clin. Pathol. 126 (2006) 174-184
299. Meites S., and Levitt M.J. Skin puncture and blood-collecting techniques for infants proposed selected method. Clin. Chem. 25 (1979) 183-189
300. Dale J.C., and Ruby S.G. Specimen collection volumes for laboratory tests. Arch. Pathol. Lab. Med. 127 (2003) 162-168
301. Norling L.L., Smith C.H., and Landt M. Heparinized "microtainer" tube evaluated for collection of capillary blood. Clin. Chem. 30 (1984) 810-811
302. Desjardins P.R.E., Mactavish G., and Schoemperlin J. Storage of specimens in "microtainer amber tubes" protects bilirubin from degradation by light. Clin. Chem. 33 (1987) 712
303. Burns JA. "Blood collector for microcollection container", U.S. Patent No. 4,397,318, August 1983.
304. Landt M., Norling L.L., Steelman M., and Smith C.H. Monoject samplette capillary blood container with serum separator evaluated for collection of specimens for therapeutic drug assays and common clinical-chemical tests. Clin. Chem. 32 (1986) 523-526
305. Kupke I.R. Evaluation of the polyester gel barrier microtainer. Clin. Chem. 33 (1987) 1468-1469
306. Food and Drug Administration, Department of health and human services. Glass capillary tubes: joint safety advisory about potential risks. www.osha.gov/pls/oshaweb/owadisp.show-document (Accessed May 2009).
307. Meites S., Lin S.S., and Thompson C. Studies of the quality of specimens obtained by skin puncture of children. Clin. Chem. 27 (1981) 875-878
308. Cohen R, Keusch P. "Medical article having blood-containing surface", US Patent No. 6551267, April 1993.
309. Hicks J.M., Rowland G.L., and Buffone G.J. Evaluation of a new blood-collecting device (microtainer) that is suited for pediatric use. Clin. Chem. 22 (1976) 2034-2036
310. Tanaka T., Moretti M.E., Verjee Z.H., Shupak M., Ivanyi K.E., and Ito S. A pitfall of measuring lithium levels in neonates. Ther. Drug Monit. 30 (2008) 752-754
311. Coyle J.T. Psychiatric drugs in medical practice. Med. Clin. North. Am. 61 (1977) 891-905
312. Weiss M., Dullenkopf A., and Moehrlen U. Evaluation of an improved blood-conserving POCT sampling system. Clin. Biochem. 11 (2004) 977-984
313. Vermeersch P., Gijbels K., Mariën G., Lunn R., Egner W., White P., and Bossuyt X. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin. Chem. 1 (2008) 39-43
314. Stankovic A.K., and Romeo P. The role of in vitro diagnostic companies in reducing laboratory error. Clin. Chem. Lab. Med. 45 (2007) 781-788
315. Green S. Improving the preanalytical process: the focus on specimen quality. JMB 27 (2008) 343-347
316. Kricka L.J., Park J.Y., Senior M.B., and Fontanilla R. Processing controls in blood collection tubes reveals interference. Clin. Chem. 51 (2005) 2422-2423
317. Parham S. Test tube interference shows 'chink in armor'. CAP Today 19 (2005) 68-72
318. Banta HD, van Beekum WT. The regulation of medical devices and quality of medical care. Qual Assur Health Care 1990;2:127-36.